Mechanism-Based Inhibition: Deriving KI and kinact Directly from Time-Dependent IC50 Values
Open Access
- 12 August 2009
- journal article
- other
- Published by Elsevier BV in SLAS Discovery
- Vol. 14 (8), 913-923
- https://doi.org/10.1177/1087057109336751
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Evaluation of Fluorescence- and Mass Spectrometry–Based CYP Inhibition Assays for Use in Drug DiscoverySLAS Discovery, 2008
- Targeting cytochrome P450 enzymes: A new approach in anti-cancer drug developmentBioorganic & Medicinal Chemistry, 2007
- Comparison of cytochrome P450 inhibition assays for drug discovery using human liver microsomes with LC–MS, rhCYP450 isozymes with fluorescence, and double cocktail with LC–MSInternational Journal of Pharmaceutics, 2007
- Mechanism-Based Inactivation of Human Cytochrome P450 Enzymes and the Prediction of Drug-Drug InteractionsDrug Metabolism and Disposition, 2006
- High throughput P450 inhibition screens in early drug discoveryDrug Discovery Today, 2005
- AUTOMATED ASSESSMENT OF TIME-DEPENDENT INHIBITION OF HUMAN CYTOCHROME P450 ENZYMES USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ANALYSISDrug Metabolism and Disposition, 2005
- Structures of cytochrome P450 3A4Trends in Biochemical Sciences, 2005
- Mechanism-Based Inactivation of Human Cytochrome P4502C8 by Drugs in VitroThe Journal of pharmacology and experimental therapeutics, 2004
- IN VITRO DRUG INTERACTIONS OF CYTOCHROME P450: AN EVALUATION OF FLUOROGENIC TO CONVENTIONAL SUBSTRATESDrug Metabolism and Disposition, 2003
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973